Galapagos | Eiendeler

Assets Endring Dato
AstraZeneca USD 96.09B 457M 2023-09
Genmab DKK 35.24B 3.26B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GRIFOLS EUR 21.44B 623.44M 2023-12
Hikma Pharmaceutical USD 4.62B 148M 2023-06
Roche Holding CHF 84.37B 3.78B 2023-06
UCB EUR 15.38B 486M 2023-06
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Galapagos Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.